Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2254 | 2234 | 45.6 | 81% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
910 | 10558 | BILE ACIDS//FARNESOID X RECEPTOR//CEREBROTENDINOUS XANTHOMATOSIS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | FARNESOID X RECEPTOR | Author keyword | 172 | 66% | 7% | 161 |
2 | FXR | Author keyword | 98 | 58% | 5% | 115 |
3 | TGR5 | Author keyword | 87 | 79% | 3% | 56 |
4 | BILE ACID SYNTHESIS | Author keyword | 67 | 61% | 3% | 71 |
5 | CHOLESTEROL 7 ALPHA HYDROXYLASE | Author keyword | 65 | 47% | 5% | 103 |
6 | SMALL HETERODIMER PARTNER | Author keyword | 33 | 67% | 1% | 29 |
7 | BILE ACIDS | Author keyword | 30 | 12% | 10% | 226 |
8 | STEROL 12 ALPHA HYDROXYLASE | Author keyword | 26 | 100% | 0% | 11 |
9 | CYP7A1 | Author keyword | 26 | 41% | 2% | 50 |
10 | FARNESOID X RECEPTOR FXR | Author keyword | 23 | 64% | 1% | 23 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FARNESOID X RECEPTOR | 172 | 66% | 7% | 161 | Search FARNESOID+X+RECEPTOR | Search FARNESOID+X+RECEPTOR |
2 | FXR | 98 | 58% | 5% | 115 | Search FXR | Search FXR |
3 | TGR5 | 87 | 79% | 3% | 56 | Search TGR5 | Search TGR5 |
4 | BILE ACID SYNTHESIS | 67 | 61% | 3% | 71 | Search BILE+ACID+SYNTHESIS | Search BILE+ACID+SYNTHESIS |
5 | CHOLESTEROL 7 ALPHA HYDROXYLASE | 65 | 47% | 5% | 103 | Search CHOLESTEROL+7+ALPHA+HYDROXYLASE | Search CHOLESTEROL+7+ALPHA+HYDROXYLASE |
6 | SMALL HETERODIMER PARTNER | 33 | 67% | 1% | 29 | Search SMALL+HETERODIMER+PARTNER | Search SMALL+HETERODIMER+PARTNER |
7 | BILE ACIDS | 30 | 12% | 10% | 226 | Search BILE+ACIDS | Search BILE+ACIDS |
8 | STEROL 12 ALPHA HYDROXYLASE | 26 | 100% | 0% | 11 | Search STEROL+12+ALPHA+HYDROXYLASE | Search STEROL+12+ALPHA+HYDROXYLASE |
9 | CYP7A1 | 26 | 41% | 2% | 50 | Search CYP7A1 | Search CYP7A1 |
10 | FARNESOID X RECEPTOR FXR | 23 | 64% | 1% | 23 | Search FARNESOID+X+RECEPTOR+FXR | Search FARNESOID+X+RECEPTOR+FXR |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | FARNESOID X RECEPTOR | 242 | 47% | 17% | 377 |
2 | FXR | 240 | 70% | 9% | 200 |
3 | BILE ACID RECEPTOR | 162 | 80% | 4% | 99 |
4 | NEGATIVE FEEDBACK REGULATION | 145 | 60% | 7% | 158 |
5 | CHOLESTEROL 7 ALPHA HYDROXYLASE GENE | 80 | 57% | 4% | 94 |
6 | CHOLESTEROL 7 ALPHA HYDROXYLASE | 76 | 40% | 7% | 148 |
7 | ORGANIC SOLUTE TRANSPORTER | 67 | 73% | 2% | 51 |
8 | ORPHAN NUCLEAR RECEPTOR | 61 | 24% | 10% | 225 |
9 | SMALL HETERODIMER PARTNER | 60 | 45% | 5% | 101 |
10 | BILE ACID SYNTHESIS | 54 | 28% | 7% | 161 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Bile acid signaling and liver regeneration | 2015 | 7 | 73 | 62% |
Bile acid receptors as targets for drug development | 2014 | 36 | 159 | 57% |
Targeting bile-acid signalling for metabolic diseases | 2008 | 288 | 145 | 71% |
Farnesoid X receptor: a master regulator of hepatic triglyceride and glucose homeostasis | 2015 | 4 | 60 | 72% |
Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation | 2009 | 386 | 342 | 54% |
Bile acids: regulation of synthesis | 2009 | 217 | 147 | 72% |
Tissue-specific actions of FXR in metabolism and cancer | 2015 | 3 | 141 | 62% |
The bile acid TGR5 membrane receptor: From basic research to clinical application | 2014 | 16 | 84 | 60% |
Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease | 2012 | 54 | 157 | 73% |
Beyond intestinal soap-bile acids in metabolic control | 2014 | 13 | 125 | 64% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GENE REGULAT DRUG DISCOVERY | 12 | 49% | 0.8% | 18 |
2 | PHARMACEUT DEV PHYS PROPERTIES DEVELOPABIL | 9 | 83% | 0.2% | 5 |
3 | GI 15A | 8 | 70% | 0.3% | 7 |
4 | EXPT MOL HEPATOL | 6 | 27% | 0.9% | 20 |
5 | DIPARTIMENTO SCI CHIRURG BIOMED | 4 | 75% | 0.1% | 3 |
6 | METAB DRUG DISCOVERY | 4 | 75% | 0.1% | 3 |
7 | UNITE RECH 545 | 4 | 56% | 0.2% | 5 |
8 | BIOCHEM MOL PATHOL | 4 | 15% | 1.1% | 25 |
9 | INTEGRAT MED SCI | 4 | 11% | 1.4% | 32 |
10 | CARDIOVASC METAB DIS DISCOVERY | 3 | 100% | 0.1% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000185100 | BILE ACID MALABSORPTION//SEHCAT//75SEHCAT |
2 | 0.0000155827 | INTRAHEPATIC CHOLESTASIS OF PREGNANCY//PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS//ABCB11 |
3 | 0.0000129669 | CALCULUS BOVIS//SULFATED BILE ACID//URINARY SULFATED BILE ACID |
4 | 0.0000105468 | FGF 21//FIBROBLAST GROWTH FACTOR 21//BETA KLOTHO |
5 | 0.0000100720 | URSODEOXYCHOLIC ACID//TAUROURSODEOXYCHOLIC ACID//TAUROURSODEOXYCHOLATE |
6 | 0.0000098035 | LIVER X RECEPTOR//LXR//LIVER X RECEPTORS |
7 | 0.0000097004 | CEREBROTENDINOUS XANTHOMATOSIS//CHOLESTANOL//BILE ALCOHOLS |
8 | 0.0000085002 | PREGNANE X RECEPTOR//PXR//CONSTITUTIVE ANDROSTANE RECEPTOR |
9 | 0.0000075187 | ALIMENTARY HYPERCHOLESTEROLEMIA//ACTIVATION OF NEUTROPHILS//AT III DEFICIENCY |
10 | 0.0000070403 | GUGGULSTERONE//COMMIPHORA WIGHTII//COMMIPHORA MYRRHA |